TCT 139: OCT Insights with Safety and Efficacy Outcomes of Intravascular Lithotripsy Use for Severely Calcified Coronary Artery Disease

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Boston Scientific Corporation; Medtronic</li></ul>